Is Ochratoxin A safe for babies and kids?
High risk for kidsInfants are more vulnerable to Ochratoxin A than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What is ochratoxin a?
The IUPAC name is (2S)-2-[[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid.
Also known as: (2S)-2-[[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid, Antibiotic 9663, NCI-C56586, Phenylalanine-ochratoxin A.
- IUPAC name
- (2S)-2-[[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid
- CAS number
- 303-47-9
- Molecular formula
- C20H18ClNO6
- Molecular weight
- 403.8 g/mol
- SMILES
- CC1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl
- PubChem CID
- 442530
Risk for babies
High riskInfants are more vulnerable to Ochratoxin A than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Context-dependentPregnancy alters the metabolism and distribution of Ochratoxin A, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Regulatory consensus
6 regulatory and scientific bodies have classified Ochratoxin A. The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| IARC | 1993 | Group 2B (possibly carcinogenic to humans) | IARC Monograph 56 (1993). Sufficient evidence of carcinogenicity in experimental animals (renal cell tumors in rats and mice); limited evidence in humans. Associated epidemiologically with Balkan endemic nephropathy (BEN) and upper urinary tract urothelial carcinoma in endemic areas of Croatia, Bosnia, Bulgaria, Romania, and Serbia. |
| EPA CTX / NTP RoC | — | Reasonably Anticipated to be a Human Carcinogen | |
| EPA CTX / IARC | — | Group 2B - Possibly carcinogenic to humans | |
| EPA CTX / CalEPA | — | Known human carcinogen | |
| EPA CTX / Genetox | — | Genotoxicity: negative (Ames: negative, 0 positive / 2 negative reports) | |
| EPA CTX / Genetox | — | Genotoxicity: negative (Ames: negative, 0 positive / 2 negative reports) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter ochratoxin a
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Ochratoxin A:
-
Prevention (storage and agricultural practices)
Trade-offs: Zero point-of-use emissions; shifts emissions to power generation (grid-dependent); lower operating cost; higher capital cost; infrastructure requirements (charging, grid capacity); rapidly improving economics.Relative cost: 1.2-2×
Frequently asked questions
Is ochratoxin a safe for kids?
Infants are more vulnerable to Ochratoxin A than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What products contain ochratoxin a?
Ochratoxin A appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
What should I do if my child is exposed to ochratoxin a?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
Why do regulators disagree about ochratoxin a?
Ochratoxin A has been classified by 6 agencies including IARC, EPA CTX / NTP RoC, EPA CTX / IARC, EPA CTX / CalEPA, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.
See Ochratoxin A in the baby app
Look up products containing ochratoxin a, compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (4)
- IARC Monographs Volume 56: Ochratoxin A (1993) — regulatory
- EFSA Panel on Contaminants: Risks to Human Health Related to Ochratoxin A in Food (Scientific Opinion) (2020) — regulatory
- WHO Safety Evaluation of Certain Mycotoxins in Food: Ochratoxin A (2001) — regulatory
- ASPCA Animal Poison Control Center: Mycotoxin Toxicosis in Companion Animals (2021) — report
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →